Visit COVID-19 resources

[Skip to Content]

Opaque intraocular lens implantation – (Eye Journal AOP)

Mar 05
2015

Opaque intraocular lens implantation Eye advance online publication, February 27 2015. doi:10.1038/eye.2015.15 Authors: J W L Gong, U O’Colmain & C J MacEwen

  • 5 March 2015

Comparison of visual field progression between temporally tilted disc and nontilted disc, in patients with normal tension glaucoma – (Eye Journal AOP)

Mar 05
2015

Comparison of visual field progression between temporally tilted disc and nontilted disc, in patients with normal tension glaucoma Eye advance online publication, February 27 2015. doi:10.1038/eye.2015.17 Authors: Y-J Choy, Y Kwun, J C Han & C Kee

  • 5 March 2015

Response to ‘Opaque intraocular lens implantation’ – (Eye Journal AOP)

Mar 05
2015

Response to ‘Opaque intraocular lens implantation’ Eye advance online publication, February 27 2015. doi:10.1038/eye.2015.19 Authors: I H Yusuf, T H M Fung & C K Patel

  • 5 March 2015

Reply to ‘Lack of positive effect of intravitreal bevacizumab in central serous chorioretinopathy: meta-analysis and review’ – (Eye Journal AOP)

Mar 05
2015

Reply to ‘Lack of positive effect of intravitreal bevacizumab in central serous chorioretinopathy: meta-analysis and review’ Eye advance online publication, February 27 2015. doi:10.1038/eye.2015.5 Authors: K Lee & Y-R Chung

  • 5 March 2015

Methodological remarks concerning the recent meta-analysis on the effect of intravitral bevacizumab in central serous chorioretinopathy – (Eye Journal AOP)

Mar 05
2015

Methodological remarks concerning the recent meta-analysis on the effect of intravitral bevacizumab in central serous chorioretinopathy Eye advance online publication, February 27 2015. doi:10.1038/eye.2015.8 Authors: T N Sergentanis & I P Chatziralli

  • 5 March 2015